Barclays
TWST icon

Barclays’s Twist Bioscience TWST Stock Holding History

Barclays’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-60,000
Closed -$2.06M – 5305
2024
Q1 		$2.06M Buy
+60,000
New +$2.17M ﹤0.01% 2548

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Barclays's TWST Position: Q1 2026 in Review

Barclays reduced its Twist Bioscience (TWST) stake by 94% in Q1 2026, selling an estimated $8.19M and leaving 11,359 shares worth $540K. The position accounts for ﹤0.01% of the portfolio, ranked #3155.

Barclays first reported a position in TWST in Q4 2018 and has held it in 30 quarters since. The position peaked at $13M in Q2 2023. 280 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • Barclays held 11,359 shares of Twist Bioscience worth $540K as of Q1 2026.
  • Barclays sold 182,712 Twist Bioscience shares in Q1 2026, an estimated $8.19M.
  • Twist Bioscience made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3155 holding.
  • Barclays first reported a position in Twist Bioscience in Q4 2018 and has held it in 30 quarters since.
  • Barclays's Twist Bioscience position peaked at $13M in Q2 2023.
  • 280 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.